Gene · 3783
Papers2,742
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,742
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glycolysis-Related LINC02432/Hsa-miR-98-5p/HK2 Axis Inhibits Ferroptosis and Predicts Immune Infiltration, Tumor Mutation Burden, and Drug Sensitivity in Pancreatic Adenocarcinoma. | Front Pharmacol | 2022 | 35795552 | PubTator, text mining | PubMed |
| An in silico-in vitro pipeline for drug cardiotoxicity screening identifies ionic pro-arrhythmia mechanisms. | Br J Pharmacol | 2022 | 35781252 | PubTator, text mining | PubMed |
| TLR Signaling Pathway Gene Polymorphisms, Gene-Gene and Gene-Environment Interactions in Allergic Rhinitis. | J Inflamm Res | 2022 | 35769128 | PubTator, text mining | PubMed |
| SNTA1 gene rescues ion channel function and is antiarrhythmic in cardiomyocytes derived from induced pluripotent stem cells from muscular dystrophy patients. | Elife | 2022 | 35762211 | PubTator, text mining | PubMed |
| Rab35 GTPase positively regulates endocytic recycling of cardiac KATP channels. | Channels (Austin) | 2022 | 35754325 | PubTator, text mining | PubMed |
| Diet evolution of carnivorous and herbivorous mammals in Laurasiatheria. | BMC Ecol Evol | 2022 | 35729512 | PubTator, text mining | PubMed |
| The Ion Channel-Related Gene Signatures Correlated With Diagnosis, Prognosis, and Individualized Treatment in Patients With Clear Cell Renal Cell Carcinoma. | Front Pharmacol | 2022 | 35721115 | PubTator, text mining | PubMed |
| KCNN4 is a Potential Biomarker for Predicting Cancer Prognosis and an Essential Molecule that Remodels Various Components in the Tumor Microenvironment: A Pan-Cancer Study. | Front Mol Biosci | 2022 | 35720112 | PubTator, text mining | PubMed |
| Polyisocyanide hydrogels with tunable nonlinear elasticity mediate liver carcinoma cell functional response. | Acta Biomater | 2022 | 35718101 | PubTator, text mining | PubMed |
| Identification of Prognosis-Related Molecular Subgroups and Construction of a Prognostic Prediction Model Using Immune-Related Genes in Pancreatic Cancer. | J Oncol | 2022 | 35712127 | PubTator, text mining | PubMed |
| Cm28, a scorpion toxin having a unique primary structure, inhibits KV1.2 and KV1.3 with high affinity. | J Gen Physiol | 2022 | 35699659 | PubTator, text mining | PubMed |
| Central fibrous area in the glomerular vascular pole consists of fibrous collagens and is associated with advanced age: a cross-sectional study. | BMC Nephrol | 2022 | 35690711 | PubTator, text mining | PubMed |
| KCNN4 may weaken anti-tumor immune response via raising Tregs and diminishing resting mast cells in clear cell renal cell carcinoma. | Cancer Cell Int | 2022 | 35689211 | PubTator, text mining | PubMed |
| BK Channel in the Physiology and in the Cancer of Pancreatic Duct: Impact and Reliability of BK Openers. | Front Pharmacol | 2022 | 35685628 | PubTator, text mining | PubMed |
| Metformin Reduces Potassium Currents and Prolongs Repolarization in Non-Diabetic Heart. | Int J Mol Sci | 2022 | 35682699 | PubTator, text mining | PubMed |
| Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis. | Br J Clin Pharmacol | 2022 | 35679331 | PubTator, text mining | PubMed |
| Gram-selective antibacterial peptide hydrogels. | Biomater Sci | 2022 | 35678287 | PubTator, text mining | PubMed |
| GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer. | NPJ Breast Cancer | 2022 | 35676392 | PubTator, text mining | PubMed |
| The Four Key Genes Participated in and Maintained Atrial Fibrillation Process via Reprogramming Lipid Metabolism in AF Patients. | Front Genet | 2022 | 35669184 | PubTator, text mining | PubMed |
| The Homeostasis of Cartilage Matrix Remodeling and the Regulation of Volume-Sensitive Ion Channel. | Aging Dis | 2022 | 35656105 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3783/papers?page=27